Activating Transcription Factor 5 (ATF5) (Middle Region) Peptid
Kurzübersicht für Activating Transcription Factor 5 (ATF5) (Middle Region) Peptid (ABIN8093905)
Target
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- ATF5 Peptide - middle region
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-ATF5 antibody ( ARP57977_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- ATF5 (Activating Transcription Factor 5 (ATF5))
-
Hintergrund
-
Background Information: ATF5 belongs to the bZIP family. It is transcriptional activator which binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in many viral and cellular promoters and blocks the differentiation of neuroprogenitor cells into neurons. Its transcriptional activity is enhanced by CCND3 and slightly inhibited by CDK4. Loss of ATF5 is associated with hepatocellular carcinoma.
Alternative Symbols: ATFX, FLJ34666, HMFN0395
-
Molekulargewicht
- 31kDa
-
Gen-ID
- 22809
-
NCBI Accession
- NP_036200
-
UniProt
- B3KND3
Target
-